Xencor (XNCR) EBT Growth (3y) (2016 - 2026)
Xencor (XNCR) EBT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -29.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.99% |
| Dec 31, 2025 | 30.04% |
| Sep 30, 2025 | 42.48% |
| Jun 30, 2025 | 19.95% |
| Mar 31, 2025 | -57.03% |
| Dec 31, 2024 | -37.69% |
| Sep 30, 2024 | -5.68% |
| Jun 30, 2024 | -6.90% |
| Mar 31, 2024 | -66.11% |
| Dec 31, 2023 | 2.61% |
| Sep 30, 2023 | -24.59% |
| Jun 30, 2023 | -26.63% |
| Mar 31, 2023 | -93.58% |
| Dec 31, 2022 | 22.92% |
| Sep 30, 2022 | -44.15% |
| Jun 30, 2022 | -55.92% |
| Mar 31, 2022 | -31.71% |
| Dec 31, 2021 | 81.86% |
| Sep 30, 2021 | -145.29% |
| Jun 30, 2021 | -29.59% |